TRIACT THERAPEUTICS INC has a total of 25 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ALK ABELLÓ AS, ATRIVA THERAPEUTICS GMBH and NEUROTEZ INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Canada | 3 | |
#5 | Argentina | 1 | |
#6 | Australia | 1 | |
#7 | Mexico | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials | |
#5 | Sugars | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | White Thomas F | 24 |
#2 | Schnipper Edward F | 6 |
#3 | Smith Steven | 5 |
#4 | Hoth Daniel F | 4 |
#5 | Nava Stephen M | 3 |
#6 | Hoth Dan | 3 |
#7 | Hoth Daniel | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019067991A1 | Iniparib formulations and uses thereof | |
WO2018237327A1 | Methods of treating glioblastoma | |
WO2018237344A1 | Methods of patient selection and treating trxr- or prdx-overexpressed cancers | |
US2015071919A1 | Cancer therapy | |
AU2014223548A1 | Cancer therapy | |
CA2742986A1 | Use of catecholic butane derivatives in cancer therapy |